Literature DB >> 4276171

Animal and human tolerance of high-dose intramuscular therapy with spectinomycin.

E Novak, J E Gray, R T Pfeifer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4276171     DOI: 10.1093/infdis/130.1.50

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  5 in total

1.  Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen.

Authors:  Santiago Ramón-García; Carol Ng; Hilary Anderson; Joseph D Chao; Xingji Zheng; Tom Pfeifer; Yossef Av-Gay; Michel Roberge; Charles J Thompson
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

2.  In vitro antibacterial activity of trospectomycin (U-63366F), a novel spectinomycin analog.

Authors:  G E Zurenko; B H Yagi; J J Vavra; B B Wentworth
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

3.  Human safety and pharmacokinetics of a single intramuscular dose of a novel spectinomycin analog, trospectomycin (U-63,366F).

Authors:  E Novak; L M Paxton; A Bye; R Patel; G E Zurenko; S F Francom
Journal:  Antimicrob Agents Chemother       Date:  1990-12       Impact factor: 5.191

4.  In vitro activity of spectinomycin against recent urinary tract isolates.

Authors:  R J Fass; R B Prior
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

5.  Developing synergistic drug combinations to restore antibiotic sensitivity in drug-resistant Mycobacterium tuberculosis.

Authors:  Charles Omollo; Vinayak Singh; Elizabeth Kigondu; Antonina Wasuna; Pooja Agarwal; Atica Moosa; Thomas R Ioerger; Valerie Mizrahi; Kelly Chibale; Digby F Warner
Journal:  Antimicrob Agents Chemother       Date:  2021-02-22       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.